Mark L. Ogden is Acting VP of Fin & Prin FO at ENZON PHARMACEUTICALS INC (ENZN). They have made 1 open-market trade across 1 company since 2011, most recently 2011-02-28.
CIK 0001496873
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $21K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENZN | 4,000 | $184K |
Shares reported on the most recent Form 4, priced at the 2011-03-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZN | BUY | 2011-02-28 | 2011-03-01 | $10.65 | $21K | -11.7% | -7.1% | -7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.